Category: Orthopaedics
-
BOOST Pharma raises $3.5 million for rare disease stem cell therapy
The Danish company plans to use the funds to advance its stem cell therapy, BT-101, for osteogenesis imperfecta, also known as brittle bone disease.
-
CustoMED raises $6 million to expand AI-driven 3D printing for orthopedic surgery
Israeli medtech startup plans to use the funding to expand orthopedic applications, pursue global approvals, and scale manufacturing.
-
Vivex Biologics completes enrollment in Phase II trial for back pain therapy
Data from the pivotal VIA Disc NP trial are anticipated in early 2026, while a second trial is already in progress, with results expected in mid-2027.
-
Allegro secures €2million to advance novel osteoarthritis treatment
Belgium’s Allegro plans to start clinical trials for hydrocelin, a once-yearly injectable for osteoarthritis relief, in 2026.
Latest posts
-
Navigating the Risks and Rewards of Biomarker-Based Surrogates and Accelerated Approval
The risks and rewards of biomarker-based surrogates are crucial for optimizing clinical trial outcomes and guiding effective treatments.
-
ASH25: Gallop’s LYT-200 shows unprecedented survival in AML
The company’s execs talk about the striking efficacy and safety signals seen in Phase I data, the science behind the molecule, and their vision for transforming AML therapy.
-
Promis reports first human evidence of aβ oligomer reduction by pmn310
PMN310 demonstrates dose-dependent reduction of amyloid-beta oligomers in human CSF, marking a key milestone in Alzheimer’s treatment development.
-
Urologic Health secures $11 million for non-invasive bladder monitoring
Urologic Health raises $11million seed funding to advance a catheter-free bladder monitoring platform toward FDA clearance and US market entry.
-
Novo Nordisk’s denecimig cuts bleeding in hemophilia A regardless of inhibitors
Phase III trial shows once‑monthly and once‑weekly denecimig (Mim8) significantly reduces annualized bleeding rate versus standard care, with up to 95% of patients bleed‑free.